TRAF3 and lymphoma: Ara-C treatment (100 μg/ml) caused a low level of cell death in Ly7 (TRAF3-loss) lymphoma (∼8%), albeit higher than in Ly1 (TRAF3-WT) lymphoma (Supplementary Fig. 7E).